GSA Capital Partners’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.73M | Sell |
184,383
-35,535
| -16% | -$333K | 0.12% | 176 |
|
|
2025
Q1 | $1.56M | Buy |
219,918
+133,577
| +155% | +$950K | 0.14% | 147 |
|
|
2024
Q4 | $1.01M | Buy |
+86,341
| New | +$1.01M | 0.07% | 402 |
|
|
2024
Q3 | – | Sell |
-70,355
| Closed | -$1.58M | – | 1889 |
|
|
2024
Q2 | $1.58M | Buy |
+70,355
| New | +$1.58M | 0.11% | 248 |
|
|
2023
Q1 | – | Sell |
-14,355
| Closed | -$501K | – | 1794 |
|
|
2022
Q4 | $501K | Buy |
14,355
+3,948
| +38% | +$138K | 0.06% | 602 |
|
|
2022
Q3 | $582K | Buy |
+10,407
| New | +$582K | 0.08% | 459 |
|
|
2020
Q1 | – | Sell |
-33,533
| Closed | -$492K | – | 1397 |
|
|
2019
Q4 | $492K | Buy |
+33,533
| New | +$492K | 0.06% | 660 |
|
|
2019
Q3 | – | Sell |
-30,555
| Closed | -$500K | – | 1609 |
|
|
2019
Q2 | $500K | Buy |
30,555
+20,181
| +195% | +$330K | 0.06% | 668 |
|
|
2019
Q1 | $177K | Buy |
+10,374
| New | +$177K | 0.02% | 1263 |
|
|
2018
Q2 | – | Sell |
-51,900
| Closed | -$1.1M | – | 1854 |
|
|
2018
Q1 | $1.1M | Buy |
+51,900
| New | +$1.1M | 0.06% | 596 |
|
|
2017
Q4 | – | Sell |
-73,100
| Closed | -$1.82M | – | 1737 |
|
|
2017
Q3 | $1.82M | Buy |
73,100
+16,400
| +29% | +$408K | 0.12% | 182 |
|
|
2017
Q2 | $907K | Buy |
+56,700
| New | +$907K | 0.06% | 638 |
|